JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marsh, D. F.
Right arrow Articles by Herring, D. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Marsh, D. F.
Right arrow Articles by Herring, D. A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 97, Issue 1, 19-24, 1949
Copyright © 1949 by American Society for Pharmacology and Experimental Therapeutics

THE CURARIFORM ACTIVITY OF N-METHYLBERBAMINE AND N-METHYLISOTETRANDINE

David F. Marsh 1 and D. A. Herring 1

1 Department of Pharmacology, West Virginia University School of Medicine, Morgantown

N-Methylberbamine iodide and N-methylisotetrandine iodide were compared with d-tubocurarine chloride pentahydrate and d-O-methyltubocurarine iodide in rats, rabbits, cats, dogs, and man. N-Methylberbamine is approximately as active a paralyzing agent as d-tubocurarine, but differs in that it possesses fewer secondary effects. N-Methylisotetrandine, the O-methyl ether of N-methylberbamine, is less active than d-tubocurarine and much less active than d-O-methyltubocurarine, the most active agent of the group.

Submitted on May 14, 1949






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1949 by the American Society for Pharmacology and Experimental Therapeutics.